¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"International journal of Middle East studies."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • middle cranial fossa
    Áß°£¸Ó¸®»À¿ì¹¬, Áߵΰ³¿Í
  • middle ear
    °¡¿îµ¥±Í, ÁßÀÌ
  • middle finger
    °¡¿îµ¥¼Õ°¡¶ô
  • middle genicular artery
    Áß°£¹«¸­µ¿¸Æ, Áß½½µ¿¸Æ
  • middle latency response
    Áß°£Àẹ¹ÝÀÀ
  • middle lobe syndrome
    Áß°£¿±ÁõÈıº
  • middle meningeal veins
    Áß°£³ú¸·Á¤¸Æ, Áß¼ö¸·Á¤¸Æ
  • middle phalanx
    Áß°£¸¶µð»À, ÁßÁö°ñ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • International Sanitary Regulations
    ±¹Á¦À§»ý±ÔÄ¢.
  • International Sensitivity Index
    ±¹Á¦¿¹¹ÎµµÁö¼ö
  • International Sensitivity Index=ISI
    ±¹Á¦¹Î°¨µµÁö¼ö
  • International System of Unit
    ±¹Á¦´ÜÀ§°è
  • SI unit => International System of Unit
    ±¹Á¦±Ô°Ý´ÜÀ§
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • fascia of middle cerebellar peduncle
  • ganglion, middle cervical
    Áß°æ½Å°æÀý, Áß°£¸ñ½Å°æÀý
  • groove for middle meningeal artery
    Áß°£³ú¸·µ¿¸Æ°í¶û
  • groove for middle temporal artery
    Áß°£Ãø µÎµ¿¸Æ°í¶û, ÁßÃøµÎµ¿¸Æ±¸(ñéö°ÔéÔÑØæÏµ).
  • groove for middle temporal artery
    Áß°£Ãø µÎµ¿¸Æ°í¶û, ÁßÃøµÎµ¿¸Æ__ñéö°ÔéÔÑØæÏµ).
  • groove for middle temporal artery
    Áß°£°üÀÚµ¿¸Æ°í¶û
  • lateral segmental branch artery of middle lobe artery<³ª> ramus lateralis rami lobi medii
    Áß°£¿±µ¿¸ÆÀÇ ¿ÜÃøÁö.
  • lateral striate artery of middle cerebral artery<³ª> rami striati artery cerebri mediae
    (Áß°£´ë³úµ¿¸ÆÀÇ) ¼±Á¶Ã¼Áö.
  • meatus, middle (of nose)
    Áߺñµµ
  • meatus, middle nasal
    Áߺñµµ
  • medi scalenus =middle scalenem
    Áß°£°æ Ãß´Á°ñ±Ù, Á߻簢±Ù.
  • medial segmental branch of middle lobe artery
    Áß°£¿±µ¿¸ÆÀÇ ³»Ãø°¡Áö, Áß¿±µ¿¸ÆÀÇ ³»Ãø?
  • meningeal branch (middle meningeal branch)
    (Áß°£)³ú¸·°¡Áö
  • middle
    Áß°£
  • middle age
    Áß³â(ñéæÄ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Middle temporal gyrus
    Áß°£°üÀÚÀ̶û
    [¿¾ ¿ë¾î] ÁßÃøµÎȸ
  • Middle temporal vein
    Áß°£°üÀÚÁ¤¸Æ
    [¿¾ ¿ë¾î] ÁßÃøµÎÁ¤¸Æ
  • Middle meningeal artery
    Áß°£³ú¸·µ¿¸Æ
    [¿¾ ¿ë¾î] Á߰渷µ¿¸Æ
  • Groove for middle meningeal artery
    Áß°£³ú¸·µ¿¸Æ°í¶û
    [¿¾ ¿ë¾î] Á߰渷µ¿¸Æ±¸
  • Middle meningeal veins
    Áß°£³ú¸·Á¤¸Æ
    [¿¾ ¿ë¾î] Á߰渷Á¤¸Æ
  • Middle cerebral artery
    Áß°£´ë³úµ¿¸Æ
    [¿¾ ¿ë¾î] Áß°£´ë³úµ¿¸Æ
  • Middle cerebral artery
    Áß°£´ë³úµ¿¸Æ
    [¿¾ ¿ë¾î] Áß´ë³úµ¿¸Æ
  • Middle phalanges
    Áß°£¸¶µð»À
    [¿¾ ¿ë¾î] ÁßÀý°ñ
  • Middle coat
    Áß°£¸·
    [¿¾ ¿ë¾î] Á߸·
  • Middle cranial fossa
    Áß°£¸Ó¸®»À¿ì¹¬
    [¿¾ ¿ë¾î] Áߵΰ³¿Í
  • Middle articular surface for talus
    Áß°£¸ñ¸»°üÀý¸é
    [¿¾ ¿ë¾î] Á߰Űñ°üÀý¸é
  • Middle cervical ganglion
    Áß°£¸ñ½Å°æÀý
    [¿¾ ¿ë¾î] Áß°æ½Å°æÀý
  • Middle cervical cardiac nerve
    Áß°£¸ñ½ÉÀå½Å°æ
    [¿¾ ¿ë¾î] Áß°æ½ÉÀå½Å°æ
  • Middle genicular artery
    Áß°£¹«¸­µ¿¸Æ
    [¿¾ ¿ë¾î] Áß½½µ¿¸Æ
  • Middle calcaneal articular surface
    Áß°£¹ß²ÞÄ¡°üÀý¸é
    [¿¾ ¿ë¾î] ÁßÁ¾°ñ°üÀý¸é
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
IPA immunoperoxidase assay; incontinentia pigmenti achromians; independent physician or practice associa...
AJKD American Journal of Kidney Diseases
JOC Journal of Oncologic Clinical(?)
AEM Academic Emergency Medicine [journal]; analytical electron microscopy; ambulatory electrocardiograph...
AM Academic Medicine [journal]; actomyosin; acute myelofibrosis; adult male; adult monocyte; aerospace ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
SAO South-East Asian ovalocytosis
CES-D Center for Epidemiologic Studies - Depression
CES-D Center for Epidemiologic Studies - Depression Scale
CES-D Center for Epidemiological Studies Depression
CESD Centers for Epidemiological Studies Depression Scale
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • middle genicular artery
    Áß°£ ¹«¸­ µ¿¸Æ, Áß½½µ¿¸Æ
    ±â¿øÀº ½½¿Íµ¿¸Æ. ºÐÁö´Â ¾øÀ½. ºÐÆ÷´Â ½½°üÀý, ½ÊÀÚÀδë, Ȱ¸·, ÀÍ»óÁÖ¸§.
  • middle lobe
    Áß°£¿±, Áß¿±
  • middle lung field
    Áß Æó ¾ß
  • middle meningeal vein
    Á߰ݸ· Á¤¸Æ, Áß°£ ³ú¸· Á¤¸Æ
    Á߰渷 µ¿¸ÆÀÇ ¹ÝÇà Á¤¸Æ. À͵¹±Ù Á¤¸ÆÃÑÀ¸·Î °³±¸ÇÑ´Ù.
  • middle nasal concha
    Áߺñ°©°³
  • middle otitis
    ÁßÀÌ¿°
  • middle palatal bar
    Áß¾Ó ±¸°³°£
  • middle rectal vein
    Áß Á÷Àå Á¤¸Æ, Áß°£ Á÷Àå Á¤¸Æ, Áß°£ °ðâÀÚ Á¤¸Æ
    Á÷Àå Á¤¸ÆÃÑ¿¡¼­ Ç÷¾×À» ¹Þ¾Æ, ³»Àå°ñ Á¤¸Æ ¹× »óÁ÷Àå Á¤¸ÆÀ¸·Î ¿î¹ÝÇÏ´Â Á¤¸Æ.
  • middle temporal artery
    Áß ÃøµÎ µ¿¸Æ, Áß°£ ÃøµÎ µ¿¸Æ, Áß°£ °üÀÚ µ¿¸Æ
    ÃøµÎ³»±Ù¿¡¼­ ½ÃÀÛÇÏ¿© ±Ù¸· ¾Æ·¡¸¦ °ü°ñ±îÁö ÇÏÇàÇϸç, À̰÷¿¡¼­ ºÐÁöÇÏ¿© ̵̿µÎ µ¿¸Æ°ú ¸¸³­´Ù.
  • middle third
    Áß¾Ó 1/3
    Ä¡¾Æ¸¦ 3µîºÐÇÏ¿´À» ¶§ Áß¾Ó ºÎÀ§¸¦ ÀǹÌÇÑ´Ù.
  • middle trace
    Áß¾Ó °æ·Î
  • middle turn
    Áß°£ ȸÀü
  • posterior, middle superior alveolar nerve plexus
    ÈÄÁß»óÄ¡Á¶ ½Å°æÃÑ
  • right middle lobe
    ¿À¸¥ Áß°£¿±, ¿ìÁß¿±
  • superficial middle cerebral vein
    ¾èÀº Áß°£ ´ë³ú Á¤¸Æ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
International Committee of the Red Cross A neutral Swiss organization serving as an intermediary between contending forces in armed conflict, in civil war, or internal strife, to help victims receive protection and other humanitarian assistance under the Geneva Conventions in accordance with the fundamental principles of the Red Cross.
(05 Mar 2000)
international cooperation The interaction of persons or groups of persons representing various nations in the pursuit of a common goal or interest.
(12 Dec 1998)
international council of nurses An international professional organization composed of one association per country for the purpose of improving and developing nursing's contribution to the promotion of health and care of the sick.
(12 Dec 1998)
international educational exchange The exchange of students or professional personnel between countries done under the auspices of an organization for the purpose of further education.
(12 Dec 1998)
International Labour Organization Classification ILO 1980 International Classification of Radiographs of the Pneumoconioses; a system for qualitative and semiquantitative description of the chest radiographic findings caused by pneumoconiosis, designed for epidemiologic studies; supersedes classifications of 1950, 1958, 1968, and 1971.
(05 Mar 2000)
international normalised ratio System established by the world health organization and the international committee on thrombosis and haemostasis for monitoring and reporting blood coagulation tests. Under this system, results are standardised using the international sensitivity index for the particular test reagent/instrument combination used.
(12 Dec 1998)
international system of units A system of physical units in which the fundamental quantities are length, time, mass, electric current, temperature, luminous intensity, and amount of substance, and the corresponding units are the meter, second, kilogram, ampere, kelvin, candela, and mole. The system has been given official status and recommended for universal use by the general conference on weights and measures.
(12 Dec 1998)
international unit The amount of a substance, such as a drug, hormone, vitamin, enzyme, etc., that produces a specific effect as defined by an international body and accepted internationally; e.g., for an enzyme it is umole of product formed (or substrate consumed) per minute.
Synonym: unit.
(05 Mar 2000)
Leiter International Performance Scale A nonverbal (performance) test for measuring intelligence which contains norms for each age between 2 and 18; originally developed as a method of assessing the comparative intellectual abilities of Caucasian, Chinese, and Japanese children, but now occasionally used for assessing slow learners and those who are blind, deaf, or verbally handicapped.
(05 Mar 2000)
retrospective studies Studies used to test aetiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
(12 Dec 1998)
pharmalogical studies <pharmacology> Studies to assess the potential harmful or other effects of drugs
(16 Dec 1997)
clinical studies <pharmacology> Human studies that are designed to measure the safety, efficacy, and appropriate dosage of a new drug or biological. Clinical studies routinely involve the use of a placebo group that is given an inactive substance that looks like the test product.
(14 Nov 1997)
cohort studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesised to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.
(12 Dec 1998)
combination studies <pharmacology> Studies in which a new drug is evaluated in combination with existing drugs.
(09 Jan 1998)
multicenter studies Controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • East Germany
    µ¿µ¶(¼öµµ Berlin)
  • East India Company
    µ¿Àεµ ȸ»ç(¿µ±¹ÀÌ 1600³â¿¡ ¼³¸³,1874³â ÇØ»ê)
  • East Indian
    µ¿ÀεµÀÇ(ÅäÀÎ,ÁÖ¹Î)
  • East Indies
    µ¿Àεµ
  • East Pakistan
    µ¿ÆÄŰ½ºÅº(1971³â¸» µ¶¸³ÇÏ¿© Bangladesh°¡ µÊ)
  • East Side
    ´º¿å Manhattan¼¶ µ¿ºÎÀÇ ÇÏÃþ À̹ΠÁö±¸
  • East Sussex
    À×±Û·£µå ³²µ¿ºÎÀÇ ÁÖ
  • Far East
    ±Øµ¿
  • Near East
    ±Ùµ¿(¾Æ¶óºñ¾Æ,ºÏµ¿¾ÆÇÁ¸®Ä«,µ¿³²¾Æ½Ã¾Æ,¹ßÄ­µîÀ» Æ÷ÇÔÇÏ´Â Áö¿ª)
  • Netherlands East Indies
    DUTCH EAST INDIES
  • down east
    (¹Ì)µ¿ºÎ ¿¬¾ÈÁö¹æÀ¸·Î(¿¡¼­,ÀÇ);(ƯÈ÷)Maine ÁÖ·Î(¿¡¼­,ÀÇ)
  • east
    µ¿ÂÊ;µ¿¾ç;¹Ì±¹µ¿ºÎÀÇ ¿©·¯ ÁÖ(east by north µµ¹ÌºÏ,in the east of ...ÀÇ µ¿ºÎ);µ¿ÂÊÀÇ µ¿¹«ÀÇ;µ¿Á·À¸·Î¿¡
  • middle
    ÇÑ °¡¿îµ¥ÀÇ,°¡¿îµ¥
  • Middle Dutch
    Áß¼¼(Áß±â) ³×´ú¶õµå ¸»
  • Middle Eastern
    Áßµ¿ÀÇ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á